Ultima Genomics Announces UG 100TM Sequencing Platform Selected For UK Biobank's Groundbreaking Human Proteome Study
The UK Biobank project, announced today, aims to investigate how fluctuations in protein levels during mid- to late-life may influence <a target= ...
Meiji Seika Pharma Co., Ltd.: Meiji Seika Pharma Invests in MPM BioImpact's New Technologies and Virology Strategy
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo; President and Representative Director: Daikichiro Kobayashi, hereinafter "Meiji") announced that the company has concluded an investment agreement wi ...
Le Lézard46m
Meiji Seika Pharma Invests in MPM BioImpact's New Technologies and Virology Strategy
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo; President and Representative Director: Daikichiro Kobayashi, hereinafter "Meiji") announced that the company has concluded an investment agreement ...